Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 3 2

Status

Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 3Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Skin Neoplasms 3Kasabach-Merritt Syndrome 2Kaposiform Hemangioendothelioma 2Waldenstrom Macroglobulinemia 1Renal Transplant Patients at High-risk for Skin Cancer 1Refractory Solid Tumors 1Peutz-Jeghers Syndrome 1Neoplasms, Plasma Cell 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leiomyoma 1Hereditary Sensory and Autonomic Neuropathies 1Hemangioma 1Angiomyolipoma 1

Interventions

Sirolimus 3aldesleukin 2Tacrolimus 2Cyclosporine 2relatlimab 1oxycodone-acetaminophen 1abobotulinumtoxinA 1Vemurafenib 1Sodium Chloride 1Prednisone 1Nivolumab 1Mycophenolic Acid 1Meloxicam 1Ipilimumab 1Interleukins 1Interleukin-2 1Fluorouracil 1Everolimus 1Bleomycin 1Azathioprine 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Skin Neoplasms × Sirolimus × Clear all
NCT07426484 2026-02-23

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

Dana-Farber Cancer Institute

Phase 4 Not yet recruiting
80 enrolled
DermatologicLymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Waldenstrom Macroglobulinemia, Skin Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasms, Plasma Cell

NCT00866684 2025-03-14

PROSKIN

Charite University, Berlin, Germany

Phase 4 Terminated
44 enrolled 7 charts
Dermatologic

Skin Neoplasms

NCT00129961 2012-04-11

Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients

Wyeth is now a wholly owned subsidiary of Pfizer

Phase 4 Completed
86 enrolled 22 charts
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡